Prothena Corporation plc - Ordinary Shares (PRTA): Price and Financial Metrics
PRTA Price/Volume Stats
| Current price | $14.40 | 52-week high | $41.54 |
| Prev. close | $14.05 | 52-week low | $13.22 |
| Day low | $13.49 | Volume | 629,600 |
| Day high | $14.58 | Avg. volume | 583,076 |
| 50-day MA | $17.79 | Dividend yield | N/A |
| 200-day MA | $21.70 | Market Cap | 774.85M |
PRTA Stock Price Chart Interactive Chart >
Prothena Corporation plc - Ordinary Shares (PRTA) Company Bio
Prothena Corporation plc is a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapy programs for the potential treatment of diseases that involve amyloid or cell adhesion. The company was founded in 2012 and is based in Dublin, Ireland.
PRTA Price Returns
| 1-mo | -12.99% |
| 3-mo | -33.67% |
| 6-mo | -28.14% |
| 1-year | -56.00% |
| 3-year | -75.60% |
| 5-year | 34.39% |
| YTD | -60.37% |
| 2023 | -39.68% |
| 2022 | 21.96% |
| 2021 | 311.32% |
| 2020 | -24.13% |
| 2019 | 53.69% |
Continue Researching PRTA
Want to do more research on Prothena Corp plc's stock and its price? Try the links below:Prothena Corp plc (PRTA) Stock Price | Nasdaq
Prothena Corp plc (PRTA) Stock Quote, History and News - Yahoo Finance
Prothena Corp plc (PRTA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...